Nov 2, 2024, 17:34
Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a recent article by Yuchen Liu on X:
“Very interesting study in Blood Journal looking at Pegcrisantaspase + Ven in R/R AML (68% of patients with prior Ven exposure)!”
Authors: Yuchen Liu, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56
Nov 13, 2024, 15:46
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29